
Melodi
Innovative soft tissue device for breast reconstruction, eluting antibiotics and fully absorbable, reducing complications and re-operations.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $10.8m | Series A | |
Total Funding | 000k |
Related Content
Melodi Health is a pioneering company in the field of reconstructive surgery, specifically focusing on breast reconstruction for women who have undergone mastectomies. The company operates in the healthcare and medical device market, targeting both patients and surgeons. Its core product, the Melodi Matrix, is a development-stage soft tissue device designed to elute antibiotics directly into the tissue and fully absorb into the body. This innovative product aims to reduce complications and the need for re-operations, which are common issues in breast reconstruction surgeries. The Melodi Matrix features a macroporous structure that permits tissue ingrowth and is pliable to allow for tissue expansion, making it the first of its kind in the market. The company generates revenue through the sale of its medical devices, primarily targeting hospitals and surgical centers involved in breast reconstruction procedures. Currently, Melodi Health is conducting clinical trials to further validate the efficacy and safety of the Melodi Matrix.
Keywords: breast reconstruction, soft tissue device, antibiotics, absorbable, macroporous, tissue ingrowth, pliable, clinical trials, healthcare, medical device.